Harpoon Therapeutics, Inc. Stock
Equities
HARP
US41358P2056
Biotechnology & Medical Research
Latest transcript on Harpoon Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Frank Lanza
DFI | Director of Finance/CFO | 62 | 19-03-31 |
Chatan Charan
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-31 |
Holger Wesche
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-09-30 |
1st Jan change | Capi. | |
---|---|---|
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |